SCHEMBL20062836

SCHEMBL20062836

c1ccc2c(c1)sc1ccc(-c3ccc4c(c3)-c3cc5c6ccccc6c6ccccc6c5cc3-c3cc(-c5ccc6sc7ccccc7c6c5)ccc3-c3cc5c6ccccc6c6ccccc6c5cc3-4)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.48
MAPT P10636 5/20 0.41
ALDH1A1 P00352 5/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
POLB P06746 1/20 0.39
ALOX5 P09917 1/20 0.39
PIM3 Q86V86 1/20 0.38
CYP1A2 P05177 1/20 0.38
NPC1 O15118 2/20 0.37
MEN1 O00255 1/20 0.37
APAF1 O14727 1/20 0.37
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
XBP1 P17861 1/20 0.37
PTBP1 P26599 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20062833 1.00 GPR3 (0.48) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062843 1.00 GPR3 (0.48) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062751 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062764 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062767 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062765 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062758 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062763 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062762 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL20062752 0.98 GPR3 (0.47) GPR3MAPTALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608185-B2 Organic electroluminescent materials and devices UNIVERAL DISPLAY CORPORATION (US) 2020-03-31 US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108844-A1 Organic Electroluminescent Materials and Devices SLCO4C1, SLCO2A1, SLCO2B1 GPR3 836/4885MAPT 934/4885ALDH1A1 1333/4885
US-10608185-B2 Organic electroluminescent materials and devices SLCO4C1, SLCO2A1, SLCO2B1 GPR3 836/4885MAPT 934/4885ALDH1A1 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.